Cytogenetic risk classification maintains its prognostic significance in transplanted <i>FLT3‐ITD</i> mutated acute myeloid leukemia patients: On behalf of the <scp>acute leukemia working party</scp> / <scp>European society of blood and marrow transplantation</scp>-Reference-Cited by-同舟云学术

Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party / European society of blood and marrow transplantation

Published:2022-01-03 Issue:3 Volume:97 Page:274-282
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Nagler Arnon¹^ORCID,Labopin Myriam²,Craddock Charles³,Socié Gerard⁴,Yakoub‐Agha Ibrahim⁵,Gedde‐Dahl Tobias⁶,Niittyvuopio Riitta⁷,Byrne Jennifer Louise⁸,Cornelissen Jan J.⁹,Labussière‐Wallet Hélène¹⁰,Arcese William¹¹,Milpied Noel¹²,Esteve Jordi¹³,Canaani Jonathan¹⁴^ORCID,Mohty Mohamad²¹⁵

Affiliation:

1. Hematology Division, Department of Bone Marrow Transplantation, Sheba Medical Center, Faculty of Medicine Tel Aviv University Tel Aviv Israel

2. Hôpital Saint‐Antoine, EBMT ALWP Office Paris France

3. Centre for Clinical Haematology Queen Elizabeth Hospital Birmingham UK

4. Assistance Publique‐Hôpitaux de Paris, Hematology Stem Cell Transplantation Saint Louis Hospital Paris France

5. CHU de Lille, University of Lille, INSERM, U1285 Lille France

6. Hematology Department, Section for Stem Cell Transplantation Oslo University Hospital, Rikshospitalet, Clinic for Cancer Medicine Oslo Norway

7. HUCH Comprehensive Cancer Center Helsinki Finland

8. Nottingham University Nottingham UK

9. Erasmus MC‐Daniel den Hoed Cancer Centre Rotterdam Netherlands

10. Centre Hospitalier Lyon Sud, Pavillon Marcel Bérard, Service Hematologie Lyon France

11. Stem Cell Transplant Unit, Policlinico Universitario Tor Vergata University of Rome Rome Italy

12. Hematology and Cell Therapy Department Bordeaux University Hospital Bordeaux France

13. Hematology Department, Hospital Clínic of Barcelona, IDIBAPS University of Barcelona Barcelona Spain

14. Hematology Division Department of Hematology, Sheba Medical Center, Faculty of Medicine, Tel Aviv University Tel Aviv Israel

15. Department of Haematology, Saint Antoine Hospital INSERM UMR 938 and Sorbonne University Paris France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26442

Reference37 articles.

1. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

2. Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia

3. Impact of FLT3ITD mutant allele level on relapse risk in intermediate-risk acute myeloid leukemia

4. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance

5. Role of Allogeneic Transplantation for FLT3/ITD Acute Myeloid Leukemia: Outcomes from 133 Consecutive Newly Diagnosed Patients from a Single Institution

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party;American Journal of Hematology;2024-01-02

2. Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia;Expert Review of Hematology;2023-04-17

3. Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;Bone Marrow Transplantation;2023-02-23